A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity
From MaRDI portal
Publication:2415802
DOI10.1016/J.JTBI.2019.03.025zbMATH Open1412.92045OpenAlexW2925658440WikidataQ92727498 ScholiaQ92727498MaRDI QIDQ2415802FDOQ2415802
Authors: Robinson F. Alvarez, José A. M. Barbuto, Roberto Venegeroles
Publication date: 23 May 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2019.03.025
Recommendations
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour
- scientific article; zbMATH DE number 1303469
- Mathematical modeling and dynamic analysis of anti-tumor immune response
- A nonlinear delay model describing the growth of tumor cells under immune surveillance against cancer and its stability analysis
Cites Work
- Period Three Implies Chaos
- Modeling immunotherapy of the tumor -- immune interaction
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- Elements of applied bifurcation theory
- Cancer immunotherapy, mathematical modeling and optimal control
- Introduction to Applied Nonlinear Dynamical Systems and Chaos
- Quantitative universality for a class of nonlinear transformations
- Modeling tumor regrowth and immunotherapy
- Modeling the dichotomy of the immune response to cancer: cytotoxic effects and tumor-promoting inflammation
- Tumor evasion from immune control: Strategies of a MISS to become a MASS
- Bistability in fluctuating environments. Implications in tumor immunology
- A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction
- Title not available (Why is that?)
- Mathematical models for immunology: current state of the art and future research directions
- Tumour suppression by immune system through stochastic oscillations
- Markoff Chains--Denumerable Case
- Assessment of cancer immunotherapy outcome in terms of the immune response time features
Cited In (16)
- Modeling and analysis of nonlinear tumor‐immune interaction under chemotherapy and radiotherapy
- A mathematical model to study the impact of intra-tumour heterogeneity on anti-tumour CD\(8^+\) T cell immune response
- A mathematical model of the effector cell response to cancer
- A fit of CD4\(^+\) T cell immune response to an infection by lymphocytic choriomeningitis virus
- A two-phenotype model of immune evasion by cancer cells
- Activation of effector immune cells promotes tumor stochastic extinction: a homotopy analysis approach
- Existence and bifurcation of non-constant positive steady states for a tumor-immune model
- Spatial patterns and bifurcation analysis of a diffusive tumour-immune model
- Fitting parameters and therapies of ODE tumor models with senescence and immune system
- Dynamical analysis of a melanoma model with immune response
- Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study
- Mathematical modeling approach of cancer immunoediting reveals new insights in targeted-therapy and timing plan of cancer treatment
- Developing and studying the dynamical behavior of a nonlinear mathematical model for cancers with tumor by considering immune system role
- Dynamics of a Mathematical Model of Cancer and Immunoediting Scenarios Under the Variation of the Immune Cell Activation Rate
- Space-velocity thermostatted kinetic theory model of tumor growth
- A mathematical model of cell-mediated immune response to tumor
Uses Software
This page was built for publication: A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2415802)